13/11/2024  12:33:46 Chg. -0.060 Volume Bid13:10:21 Demandez à13:10:21 Capitalisation boursière Dividende Y. Rapport P/E
16.880EUR -0.35% 28,858
Chiffrre d'affaires: 489,748.500
16.840Bid taille: 7,699 16.920Ask la taille: 1,443 655.79 Mio.EUR - -

Description de l'entreprise

AT&S is currently Europe’s largest printed circuit board manufacturer and one of the market leaders in high-end printed circuit board technology. Depending on technological and economic requirements, AT&S offers the widest possible range of printed circuit boards specially tailored to customers’ needs: single-sided, double-sided plated-through, multi-layer, HDI (high density interconnection, laser-drilled), IMS (insulated metallic substrate), flexible, rigid-flex and semi-flexible. The core businesses of AT&S are Mobile Devices, Automotive, Industrial, Medical, Aviation and Advanced Packaging.
 

Conseil d'administration & Conseil de surveillance

PDG
Andreas Gerstenmayer
Conseil d'administration
Petra Preining, Peter Schneider, Ingolf Schröder, Peter Griehsnig
Conseil de surveillance
Hannes Androsch, Georg Riedl, Gertrude Tumpel-Gugerell, Robert Lasshofer, Georg Hansis, Hermann Eul, Karin Schaupp, Lars Reger
 

Données de l'entreprise

Nom: AT&S Austria Technologie & Systemtechnik AG
Adresse: Fabriksgasse 13,A-8700 Leoben
Téléphone: +43-3842-200-0
Fax: +43-3842-200-216
Courriel: info@ats.net
Internet: www.ats.net
Industrie: Technology
Secteur: Hardware and Equipment
Sous-secteur: Semiconductors
Fin de l'exercice financier: 31/03
Flotte libre: 64.40%
IPO date: 16/07/1999

Relations avec les investisseurs

Nom: Johannes Mattner
Téléphone IR: +43-3842-200-5450
IR-Fax: +43-3842-200-15925
E-mail IR: j.mattner@ats.net

Calendrier de l'entreprise

CW 6 | 04/02/2025 Interim Report 3rd Quarter/9 Months
CW 20 | 15/05/2025 Preliminary Annual Figures
CW 23 | 05/06/2025 Annual Report
CW 27 | 03/07/2025 General Shareholder Meeting
CW 30 | 21/07/2025 Ex-Dividend
 

Principaux actionnaires

FreeFloat
 
64.32%
Dörflinger Privatstiftung
 
18.13%
Androsch Private Foundation
 
17.55%